Letter to CMS Regarding Oversight of the Medicaid Drug Rebate Program
Excerpt: “OIG detailed that for the period reviewed, Medicaid may have lost $1.3 billion in base and inflation-adjusted rebates for just these 10 drugs. Even more troubling, CMS does not track misclassification errors, so it is unclear what steps CMS has taken to address these errors. Moreover, OIG reported that CMS does not have explicit legislative authority to correct misclassification errors.”
To read a copy of the letter, click here.